TrialInternational journal of clinical pharmacology and therapeutics2024

Comparison of SB17 and reference ustekinumab in healthy adults: A randomized, double-blind, single-dose, phase I study.

Hansol Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.